Osteosarcoma: evolution of treatment paradigms
- PMID: 23781130
- PMCID: PMC3678494
- DOI: 10.1155/2013/203531
Osteosarcoma: evolution of treatment paradigms
Abstract
This paper reviews the contribution of chemotherapy in the conquest of osteosarcoma. It discusses how the treatment of osteosarcoma has evolved over the last five decades, resulting in a more than fivefold increase in survival. Though the initial improvements in survival were dramatic, essentially there has been no change in the outlook for this disease over the past 30 years. The paper also highlights the necessity of a multidisciplinary approach to combat this disease and stresses the need to explore newer treatment agents in order to build on the lessons learnt from the past while striving to achieve greater levels of success.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer Journal for Clinicians. 2009;59(4):225–249. - PubMed
-
- Boyer A. The Lectures Boyer Upon Disease of the Bone. Philadelphia, Pa, USA: James Humphreys; 1805.
-
- Gross SW. Sarcoma of the long bones: based on a study of one hundred sixty five cases. The American Journal of the Medical Sciences. 1879:8338–8377.
-
- Cade S. Osteogenic sarcoma; a study based on 133 patients. Journal of the Royal College of Surgeons of Edinburgh. 1955;1(2):79–111. - PubMed
-
- Ferguson AB. Treatment of osteosarcoma. The Journal of Bone & Joint Surgery. 1940;22:92–96.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
